Asthma, Phase III

NIMBLE

Volunteers
Health Professionals

What is the purpose of this trial?

Non-inferiority study of GSK3511294 compared with mepolizumab or benralizumab in participants with severe asthma with an eosinophilic phenotype.

Trial with
GlaxoSmithKline, LLC
Ages
12 years and older
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Katie Spaulding

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Geoffrey Chupp, MD
Professor of Medicine (Pulmonary, Critical Care and Sleep Medicine ); Director, Yale Center for Asthma and Airways Disease (YCAAD), Pulmonary, Critical Care & Sleep Medicine; Director, Pulmonary Function Laboratory, Yale-New Haven Hospital, Pulmonary, Critical Care & Sleep Medicine

Sub-Investigators

Last Updated
08/11/2023
Study HIC
#2000030951